Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Want to Grow Richer? These Stocks Have Doubled in the Past 5 Years


With savvy stock-picking and a bit of patience, building wealth isn't as difficult as it is often made out to be. This is because quality businesses grow their revenue and profits, which makes their shares more valuable over time.

Shares of (NASDAQ: AZN) and Merck (NYSE: MRK) have both more than doubled over the last five years. Let's dig into what the two pharmaceutical companies accomplished that drove their stock prices higher, and whether they can keep up those strong performances. 

With a $228 billion market capitalization, AstraZeneca is the sixth-largest pharmaceutical company in the world and the second-biggest international-based drugmaker behind Novartis (NYSE: NVS).

Continue reading


Source Fool.com

Astrazeneca ADR Stock

€77.50
1.960%
Astrazeneca ADR gained 1.960% today.

Like: 0
AZN
Share

Comments